SHAREHOLDER ALERT: Investigation on Behalf of EDAP TMS S.A. Investors Announced by Law Offices of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of EDAP TMS S.A. (“EDAP” or the “Company”) (NASDAQ:EDAP). The investigation concerns possible violations of federal securities laws and focuses on statements issued by the Company concerning EDAP’s business and financial prospects.

EDAP, through its subsidiaries, develops, produces and markets minimally invasive medical devices for the treatment of urological diseases. The investigation relates to the July 28, 2014, disclosure that Food and Drug Administration (FDA) staff questioned EDAP’s safety and effectiveness data because the Company compared patients in two different studies to gather evidence, rather than a head-to-head trial. The investigation also relates to the FDA’s July 30, 2014, announcement that the panel convened to review EDAP’s submission unanimously found that EDAP had failed to demonstrate the efficacy of its product or that it had demonstrated that the benefits of the device outweighed its risk. On this news, shares of EDAP declined more than 40 percent in after-hours trading.

If you purchased shares of EDAP between February 1, 2013 and July 30, 2014, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll-Free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com

EDAP TMS (NASDAQ:EDAP)
過去株価チャート
から 6 2024 まで 7 2024